On ECHEMI
Home > Drugs > Breviscapus tablets

Breviscapus tablets

Function and Efficacy

Modern drug research has shown that breviscapine has the effects of increasing blood flow, improving microcirculation, dilating blood vessels, reducing blood viscosity, lowering blood lipids, promoting fibrinolysis, anti-thrombosis, and anti-platelet aggregation.

Ingredients

Breviscapine.

Name Description Content CAS NO. Manufacturer
BREVISCAPINIngredients

Increase blood flow, improve microcirculation, dilate blood vessels, reduce blood viscosity, lower blood lipids, promote fibrinolysis, anti-thrombosis, anti-platelet aggregation

More
116122-36-2 0

Appearance

This product is light yellow flakes; taste is light or slightly salty.

Usage and Dosage

Oral administration: 2 tablets at a time, 3 times a day.

Adverse Reactions

Not yet clear.

Precautions

It is not suitable for people in the acute stage of cerebral hemorrhage or with bleeding tendency. It is forbidden for pregnant women and breastfeeding women.

Special Population Medication

Precautions during pregnancy and lactation: Pregnant and lactating women are prohibited from using.

Drug Interactions

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Storage

Sealed and protected from light.

Packaging Specification

Each tablet weighs 0.155g (containing 20mg of breviscapine)

Validity Period

24 months

Manufacturer

Yunnan Yuyao Biopharmaceutical Co., Ltd.

  • Founded in:

    2002-03-27
  • Address:

    Yunnan Province Yuxi City High-tech Development Zone
  • Tax NO.:

    91530400734330834G
  • Registered Funds:

    65 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.